XML 47 R27.htm IDEA: XBRL DOCUMENT v3.21.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Numerator for basic and diluted net loss per share:    
Net loss attributable to Sanara MedTech common shareholders $ (4,356,440) $ (2,814,088)
Denominator for basic and diluted net loss per share:    
Weighted average shares used to compute diluted net loss per share 5,734,537 2,132,745
Basic and diluted net loss per share attributable to common shareholders $ (0.76) $ (1.32)